Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWJ1319 for Gallstone Prevention After Gastrectomy
NCT02490111Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- May 2015
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in cholelithiasis, sponsored by Daewoong Pharmaceutical. Started May 2015; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on NCT02490111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490111.